Neal R. Barshes

Barshes

Neal R. Barshes, M.D., M.P.H.

Associate Professor of Surgery

(713) 794-7892

Positions

Associate Professor of Surgery
Division of Vascular Surgery & Endovascular Therapy
Baylor College of Medicine
Chief, Vascular Surgery Section
Michael E. DeBakey VA Medical Center

Addresses

Michael E. DeBakey VA Medical Center (Hospital)
2002 Holcombe Boulevard
OCL-112
Houston, TX, 77030
United States

Education

BS from University of Illinois at Urbana-Champaign
05/1997 - Urbana-Champaign, Illinois, United States
psychology
MD from University of Illinois at Chicago College of Medicine
05/2001 - Chicago, Illinois, United States
MPH from University of Texas at Houston Health Science Center
05/2006 - Houston, Texas, United States
healthcare delivery systems
Residency at Michael E. DeBakey Department of Surgery / Baylor College of Medicine
06/2009 - Houston, Texas, United States
general surgery
Clinical Fellowship at Harvard Medical School / Brigham and Women's Hospital
06/2011 - Boston, Massachusetts, United States
vascular surgery and endovascular therapy

Certifications

General Surgery
American Board of Surgery
Vascular Surgery
American Board of Surgery
Registered Physician in Vascular Interpretation
American Registry for Diagnostic Medical Sonography

Honors & Awards

Clark Faculty Service Award
Baylor College of Medicine
Star Award for Excellence in Patient Care
Baylor College of Medicine
Gene Guinn M.D. Outstanding Teaching Faculty Award for excellence in teaching general surgery residents
Michael E. DeBakey Department of Surgery (07/2014 - 07/2015)
Outstanding Teaching Faculty Award for excellence in teaching medical students
Michael E. DeBakey Department of Surgery (07/2013 - 06/2014)
Outstanding Teaching Faculty Award for excellence in teaching medical students
Michael E. DeBakey Department of Surgery (07/2014 - 06/2015)
Top Doctor: Vascular Surgery
Houstonia Magazine
Faculty Excellence Award for Educational Materials
Norton Rose Fulbright Awards (07/2026)

Professional Interests

  • Leg bypass operations, including tibial, pedal, and pedal branch targets
  • Ewing technique for transtibial (below-knee) amputations
  • Microvascular anastomoses
  • Aortic aneurysms
  • Carotid artery operations for stroke prevention
  • Peripheral arterial disease (PAD)

Professional Statement

Dr. Neal R. Barshes is a double board-certified vascular surgeon. He diagnoses and treats the full spectrum of peripheral vascular disorders, especially peripheral artery disease (PAD) and critical limb-threatening ischemia (CLTI).
Dr. Barshes currently sees patients and operates exclusively at the Michael E. DeBakey Veterans Affairs Medical Center (MEDVAMC) in Houston, Texas.
As an academic vascular surgeon, Dr. Barshes works to develop cost-effective, resilient and equitable strategies to prevent leg amputations. He has authored more than 150 original, peer-reviewed articles to professional medical journals. He has served on guideline writing committees for the American Heart Association, the Society for Vascular Surgery, and the International Working Group for the Diabetic Foot.

For his clinical efforts, Dr. Barshes was awarded the Baylor College of Medicine Star Clinician Award “for clinical excel-lence and expertise” and the Clark Service Award for representing “Baylor’s mission, vision and values at the highest level”.

Selected Publications

Memberships

American College of Surgeons
Society for Vascular Surgery
American Diabetes Association
Society of Brigham Surgical Alumni
Texas Surgical Society

Funding

Randomized, Multicenter, Controlled Trial to Compare Best Endovascular versus Best Surgical Therapy in Patients with Critical Limb Ischemia (BEST-CLI)
#ClinicalTrials.gov ID NCT01229358
(12/01/2014 - 12/01/2022)
Grant funding from The National Institutes of Health (NIH); the National Heart, Lung and Blood Institute (NHLBI)
Prospective, randomized, multicenter trial comparing endovascular therapy (angioplasty with or without stent placement) to leg bypass surgery to improve leg circulation for limb-threatening conditions and avoidance of leg amputations.
Investigation of Rifampin to Reduce Pedal Amputations for Osteomyelitis in Diabetics (VA-INTREPID)
#ClinicalTrials.gov ID NCT03012529
$834,207.00   (08/01/2017 - 06/30/2025)
Grant funding from Veterans Health Administration Cooperative Studies Program
Prospective, randomized, double-blind, placebo-controlled multicenter trial comparing a six week course of adjunctive rifampin vs. adjunctive matched placebo added to standard antibacterial therapy for the treatment of diabetic foot osteomyelitis.
Transfusion Trigger after Operation in High Cardiac Risk Patients
#ClinicalTrials.gov ID NCT03229941
$1,370,683.00   (08/01/2017 - 06/30/2025)
Grant funding from Veterans Health Administration Cooperative Studies Program
Prospective, randomized, multicenter clinical trial that compared postoperative outcomes in a restrictive transfusion strategy (Hb < 7 gm/dl) vs. a non-restrictive transfusion strategy (Hb < 10 gm/dl) in Veterans at high cardiac risk who undergo major open vascular and general surgery operations
Randomized Clinical Trial for Ewing Amputation in the VA
#; ClinicalTrials.gov ID NCT05437562
(06/01/2026)
Grant funding from Veterans Health Administration Office of Research and Development, Clinical Science Research & Development
Prospective, randomized, multicenter clinical trial comparing ambulatory function and mobility in patients undergoing transtibial (below-knee amputation using traditional vs. Ewing surgical technique.
Impact of Colchicine on Peri-Operative Major Adverse Cardiovascular Events in Patients with Prior Coronary Revascularization: The Peri-OPerative COlchicine to Reduce Nega-tive Events (POPCORN) Trial
#ClinicalTrials.gov ID NCT05618353
(06/01/2025)
Grant funding from Veterans Affairs Office of Research and Development
Prospective, randomized, multicenter trial comparing the clinical outcomes (including perioperative major adverse cardiac events) and systemic inflammation associated with colchicine compared to placebo in patients with prior coronary revascularization or high coronary atherosclerotic burden who undergo intermediate- or high-risk non-cardiac surgery.

Log In to edit your profile